glp-1 agonists anxiety side effects Glucagon-like Peptide-1 receptor as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence The Antidepressant Effects of GLP-1

Identifying small-molecule agonists for class B1 GPCRs such as GLP-1R remains challenging due to the receptors conformational plasticity and its large, peptide-optimized binding interface (Liu et al., 2025)

The ongoing and completed clinical trials involving representative natural compounds (e.g., curcumin, resveratrol, and related phytochemicals), including their clinical indications, trial phases, and key outcomes

For instance, one study [NCT01027884] employed weekly home-based spirometry to monitor pulmonary function in patients with DMD 20

Figure 4: Patient 2 after

Perimenopause relief is rarely about finding one perfect fix

Melanotan II can only be injected with needles